Gregory Waryasz, MD
Orthopaedic Surgery · Providence, RINPI 1336469170
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,713 of the $7,972 with a category attached, or 84.2%. 9 manufacturers reported payments, led by Ossio Inc at 52.2% of the total. Reporting peaked in 2024 at $6,745 and has fallen 93.7% since, to $424 in 2025.
Across 13 payments — averaging $613.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ossio Inc$4K
- Extremity Medical$3K
- Paragon 28, Inc.$758
- Treace Medical Concepts, Inc.$273
- Carbofix Orthopedics Inc$93
- Arthrex$46
- plus $57 from 3 others
What the payments were for
- Consulting fees$6,71384%
- Travel & lodging$1742%
- Food & beverage$1,08614%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ossio Inc | 1 | $4,163 |
| Extremity Medical | 2 | $2,583 |
| Paragon 28, Inc. | 4 | $758 |
| Treace Medical Concepts, Inc. | 1 | $273 |
| Carbofix Orthopedics Inc | 1 | $93 |
| Arthrex | 1 | $46 |
| Johnson & Johnson | 1 | $25 |
| Stryker | 1 | $18 |
| Orthofix Medical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Joint prep$2,550
- CarpalFiX$2,550
- Product Portfolio$359
- Lapiplasty System$273
- Phantom Fibula Nail$266
- R3FLEX$133
How this compares
$7,972 in reported general payments places this provider in the 60th percentile of 124 orthopaedic surgery providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 14 | $102 |
| Oxycodone Hcl | 16 | $63 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Providence
- Edward PaxtonProvidence$244K
- Steven BokshanProvidence$130K
- Eric CohenProvidence$72K
- Erin HaggertyProvidence$67K
- Todd BorensteinProvidence$49K
- Mark PalumboProvidence$39K
- Brian CohenProvidence$32K
- Scott MallozziProvidence$28K
- Peter WagnerProvidence$26K
- Craig EbersonProvidence$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.